Preclinical Evaluation of Selene-Ethylenelacticamides in Tuberculosis: Effects Against Active, Dormant, and Resistant Mycobacterium Tuberculosis and In Vitro Toxicity Investigation
Natália Ferreira de Sousa,
No information about this author
Maria Eugênia G. de Freitas,
No information about this author
Maria Gabriella S. Sidrônio
No information about this author
et al.
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(2), P. 396 - 396
Published: Feb. 11, 2025
Selene-ethylenelacticamide
derivatives
have
been
suggested
as
promising
scaffolds
with
leishmanicidal
activity.
In
this
work,
we
demonstrated,
for
the
first
time,
effectiveness
of
selene-ethylenelacticamide
against
mycobacteria.
Firstly,
selene-ethylenelacticamides
inhibited
growth
laboratory
strains
Mycobacterium
tuberculosis
MIC
values
ranging
from
10
to
20
µM.
Importantly,
three
were
active
two
multi-drug-resistant
clinical
isolates
M.
similar
pan-sensitive
strains.
addition,
NC31
and
NC34
displayed
an
improved
activity
compared
group
treated
isoniazid
in
six-week
nutrient-starved
cultures.
Moreover,
toxicity
studies,
did
not
significantly
affect
viability
both
Vero
E6
HepG2
cell
lines.
Artemia
salina
nauplii
survival
at
concentrations
lower
than
100
a
synergistic
effect
when
combined
rifampicin.
Molecular
docking
simulations
used
evaluate
DprE1
dihydrofolate
reductase
enzymes
putative
targets
selene-ethylenelacticamides,
mechanisms
that
could
contribute
antitubercular
Our
findings
reveal
may
represent
hit
further
drug
optimization
future
preclinical
development
new
anti-mycobacterial
agent,
especially
cases
resistant
and/or
dormant
forms
tuberculosis.
Language: Английский
Host-Mediated Antimicrobial Effects and NLRP3 Inflammasome Modulation by Caulerpin and Its Derivatives in Macrophage Models of Mycobacterial Infections
Maria Gabriella S. Sidrônio,
No information about this author
Maria Eugênia G. de Freitas,
No information about this author
Daniel Magalhães
No information about this author
et al.
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(3), P. 561 - 561
Published: March 1, 2025
Caulerpin,
a
bis-indole
alkaloid
isolated
from
Caulerpa
racemosa,
has
several
documented
pharmacological
activities,
including
antineoplastic
and
antiviral
properties.
This
study
aimed
to
evaluate
the
anti-inflammatory
anti-tubercular
potentials
of
caulerpin
its
analogues
in
RAW
264.7
macrophages
infected
with
Mycobacterium
spp.
Additionally,
we
evaluated
cytokine
production
NLRP3
expression
this
infection
model.
Toxicity
tests
were
performed
using
Vero
E6
HepG2
cell
lines
Artemia
salina.
Pre-incubation
cells
decreased
internalized
M.
smegmatis
tuberculosis
H37Ra.
Furthermore,
treatment
smegmatis-infected
reduced
bacterial
loads.
Caulerpin
CFU
count
bacilli
H37Ra
In
addition,
diethyl
derivative
notably
found
modulate
IL-1β
TNF-α
model
after
quantifying
pro-inflammatory
cytokines
NLRP3.
derivates
did
not
affect
viability
or
nauplii
survival
toxicity
studies.
These
findings
demonstrate
that
exhibit
activity
against
show
promising
potential
for
further
efficacy
safety
evaluation.
Language: Английский